Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Effect of the Factor XIa Inhibitor Asundexian According to Baseline Infarct Pattern and on MRI Covert Infarct Outcomes.
Smith EE, Shoamanesh A, Xu L, Heenan L, Saad F, Colorado P, Chen CH, Lemmens R, De Marchis GM, Caso V, Masjuan J, Hirano T, Milanov I, Campbell BCV, Mas JL, Connolly SJ, Mundl H, Hart RG; PACIFIC-Stroke Steering Committee and Investigators. Smith EE, et al. Stroke. 2024 Feb;55(2):392-402. doi: 10.1161/STROKEAHA.123.043198. Epub 2024 Jan 4. Stroke. 2024. PMID: 38174569 Clinical Trial.
Association of CD38+ Immunophenotyping Biomarker With a Better Prognosis in Elderly Acute Myeloid Leukemia Patients.
DE Pinho Pessoa FMC, Oliveira DS, Nogueira BMD, DE Albuquerque KMC, Silva FAC, Gurgel LA, Ribeiro RM, Medeiros JC, Maciel ADR, Barreto IV, Machado AK, Machado CB, DE Moraes Filho MO, DE Moraes MEA, Khayat AS, Moreira-Nunes CA. DE Pinho Pessoa FMC, et al. Among authors: machado cb. Anticancer Res. 2024 Jun;44(6):2747-2753. doi: 10.21873/anticanres.17083. Anticancer Res. 2024. PMID: 38821591
Development and Clinical Applications of PI3K/AKT/mTOR Pathway Inhibitors as a Therapeutic Option for Leukemias.
DA Costa Machado AK, Machado CB, DE Pinho Pessoa FMC, Barreto IV, Gadelha RB, DE Sousa Oliveira D, Ribeiro RM, Lopes GS, DE Moraesfilho MO, DE Moraes MEA, Khayat AS, Moreira-Nunes CA. DA Costa Machado AK, et al. Among authors: machado cb. Cancer Diagn Progn. 2024 Jan 3;4(1):9-24. doi: 10.21873/cdp.10279. eCollection 2024 Jan-Feb. Cancer Diagn Progn. 2024. PMID: 38173664 Free PMC article. Review.
PARP1 Characterization as a Potential Biomarker for BCR::ABL1 p190+ Acute Lymphoblastic Leukemia.
Machado CB, da Silva EL, Ferreira WAS, Pessoa FMCP, de Quadros AU, Fantacini DMC, Furtado IP, Rossetti R, Silveira RM, de Lima SCG, Mello Júnior FAR, Seabra AD, Moreira ECO, de Moraes Filho MO, de Moraes MEA, Montenegro RC, Ribeiro RM, Khayat AS, Burbano RMR, de Oliveira EHC, Covas DT, de Souza LEB, Moreira-Nunes CFA. Machado CB, et al. Cancers (Basel). 2023 Nov 22;15(23):5510. doi: 10.3390/cancers15235510. Cancers (Basel). 2023. PMID: 38067214 Free PMC article.
Modelling renal defects in Bardet-Biedl syndrome patients using human iPS cells.
Williams J, Hurling C, Munir S, Harley P, Machado CB, Cujba AM, Alvarez-Fallas M, Danovi D, Lieberam I, Sancho R, Beales P, Watt FM. Williams J, et al. Among authors: machado cb. Front Cell Dev Biol. 2023 Jun 2;11:1163825. doi: 10.3389/fcell.2023.1163825. eCollection 2023. Front Cell Dev Biol. 2023. PMID: 37333983 Free PMC article.
68 results